Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shane Parfrey"'
Autor:
Shane Parfrey, Amr Abdelrahman, Daniel Blackman, Jonathan M. Blaxill, Michael S. Cunnington, John P. Greenwood, Christopher J. Malkin, Abdul M. Mozid, Jennifer A. Rossington, Murugapathy Veerasamy, Nancy Wassef, Stephen B. Wheatcroft, Heerajnarain Bulluck
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Very short duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) has recently attracted a lot of attention with the introduction of newer generations stents. This is appealing, especially in patients
Externí odkaz:
https://doaj.org/article/53ff4a31117941ec854b814dec536678
Autor:
Stephen J. Duffy, Louise Roberts, Christopher M. Reid, Melanie Freeman, Andrew W. Teh, Andrew E. Ajani, Shane Parfrey, David J Clark, Angela Brennan
Publikováno v:
Coronary Artery Disease. 32:288-294
OBJECTIVE: The aim of the review was to assess whether CHA2DS2-VASc score is predictive of mortality in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI). BACKGROUND: The CHA2DS2-VASc score is validated in predicti
Publikováno v:
European Heart Journal: Case Reports
Background Poly ADP-ribose polymerase (PARP) inhibitors target pathogenic BRCA mutations in chemotherapy-resistant malignancies. PARP inhibitors cause modest dose-dependent QT prolongation in the setting of a normal baseline QT interval. Case summary
Autor:
Joshua Michaels, Shane Parfrey, Abdul M. Mozid, Murugapathy Veerasamy, Heerajnarain Bulluck, Muzahir H. Tayebjee
Publikováno v:
Heart, Lung and Circulation. 31:e115-e116